These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1345691)

  • 21. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current concepts in the pathogenesis and treatment of abortion and septic shock. II. The physiopathological bases and outlook in the management of septic shock].
    Figueroa Damian R; Arredondo García JL
    Ginecol Obstet Mex; 1993 Dec; 61():337-43. PubMed ID: 8119603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical infections: blocking the mediator cascade responsible for sepsis and septic shock.
    Fink MP
    Curr Opin Gen Surg; 1993; ():19-25. PubMed ID: 7583965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade.
    Giroir BP
    Crit Care Med; 1993 May; 21(5):780-9. PubMed ID: 8482101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of septic shock with immunotherapy.
    Smith AL
    Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology and treatment of gram-negative sepsis.
    DiPiro JT
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S6-10. PubMed ID: 2275478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sepsis: the role of steroids and monoclonal antibodies in treatment.
    Manzullo EF
    Oncology (Williston Park); 1994 Jun; 8(6):115-20; discussion 120, 123. PubMed ID: 8074977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Corticotherapy in severe infectious states].
    Annane D; Sharshar T; Auriant I; Clair B; Raphael JC; Gajdos P
    Bull Acad Natl Med; 2000; 184(8):1631-40; discussion 1640-2. PubMed ID: 11471384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Monoclonal antibodies in the treatment of sepsis and septic shock].
    Torrabadella de Reynoso P; Salgado Remigio A; Peracaula Picart R
    Med Clin (Barc); 1992 Dec; 99(20):784-92. PubMed ID: 1460952
    [No Abstract]   [Full Text] [Related]  

  • 30. [New immunologic treatment of rheumatoid arthritis].
    Sany J
    Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New treatment approaches in sepsis].
    Bloos F; Reinhart K
    Zentralbl Chir; 2002 Mar; 127(3):174-9. PubMed ID: 11935479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The systemic septic response: multiple systems organ failure.
    Cerra FB
    Crit Care Clin; 1985 Nov; 1(3):591-607. PubMed ID: 3916795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic plasma exchange in severe sepsis or septic shock.
    Kes P
    Acta Med Croatica; 1998; 52(2):127-32. PubMed ID: 9682501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody production: polyclonal-derived biotherapeutics.
    Newcombe C; Newcombe AR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):2-7. PubMed ID: 16893686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytokines and severe sepsis].
    Baumgartner JD; Heumann D
    Rev Prat; 1993 Mar; 43(5):559-63. PubMed ID: 8341926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence.
    Escames G; Acuña-Castroviejo D; López LC; Tan DX; Maldonado MD; Sánchez-Hidalgo M; León J; Reiter RJ
    J Pharm Pharmacol; 2006 Sep; 58(9):1153-65. PubMed ID: 16945173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cortisol in critically ill patients with sepsis--physiological functions and therapeutic implications].
    Briegel J
    Wien Klin Wochenschr; 2002; 114 Suppl 1():9-19. PubMed ID: 15503552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targets for sepsis therapies: tumor necrosis factor versus interleukin-1.
    Russell DA; Thompson RC
    Curr Opin Biotechnol; 1993 Dec; 4(6):714-21. PubMed ID: 7764470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do monoclonal antibodies and anticytokines still have a future in infectious diseases?
    Cohen J; Heumann D; Glauser MP
    Am J Med; 1995 Dec; 99(6A):45S-52S; discussion 52S-53S. PubMed ID: 8585536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies in sepsis and septic shock.
    Neilson D; Rao PN
    BMJ; 1992 Mar; 304(6827):639-40. PubMed ID: 1559102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.